科研成果：科学论文与知识产权

专注给予质高价优

的生物药

科学论文

Serplulimab Combined with Chemotherapy in The Neoadjuvant Treatment of Resectable Oesophageal Squamous Cell Carcinoma: A Single-Arm Phase 2 Trial
ESMO IO 2024
Serplulimab in combination with regorafenib and hepatic artery bicarbonate infusion on the third-line treatment in advanced colorectal cancer patients with liver metastasis: study protocol of a single-arm, single-center phase II study
CSCO 2024
First-Line Serplulimab for Advanced Squamous Non-Small Cell Lung Cancer: A Multicenter, Single-Arm, Real-World ASTRUM-004R Study
ESMO Asia 2024
Is neoadjuvant chemoimmunotherapy better than chemotherapy in patients with limited-stage small cell lung cancer: a retrospective comparative study
WCLC 2024
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer: The Multicenter ASTRUM-005R Study
WCLC 2024
Perioperative serplulimab and chemotherapy in patients with resectable squamous non-small cell lung cancer: an open-label, single-arm, phase 2 trial
ESMO 2024

知识产权

专利申请数量	PCT申请数量	国内外授权专利数量	注册司法权区	申请日期	到期日	发明专利数量
809	90	134	中国大陆	2011-03-18	2031-03-18	97

304am永利